Does PALBOCICLIB Cause Gastrointestinal disorder? 312 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 312 reports of Gastrointestinal disorder have been filed in association with PALBOCICLIB (Ibrance). This represents 0.3% of all adverse event reports for PALBOCICLIB.
312
Reports of Gastrointestinal disorder with PALBOCICLIB
0.3%
of all PALBOCICLIB reports
9
Deaths
65
Hospitalizations
How Dangerous Is Gastrointestinal disorder From PALBOCICLIB?
Of the 312 reports, 9 (2.9%) resulted in death, 65 (20.8%) required hospitalization, and 3 (1.0%) were considered life-threatening.
Is Gastrointestinal disorder Listed in the Official Label?
Yes, Gastrointestinal disorder is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Gastrointestinal disorder?
METHOTREXATE (7,311)
ADALIMUMAB (6,416)
ETANERCEPT (4,834)
LEFLUNOMIDE (4,832)
ABATACEPT (4,190)
RITUXIMAB (4,154)
TOCILIZUMAB (4,145)
HYDROXYCHLOROQUINE (3,957)
PREDNISONE (3,886)
INFLIXIMAB (3,652)
Which PALBOCICLIB Alternatives Have Lower Gastrointestinal disorder Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID